Your browser doesn't support javascript.
loading
Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature.
Karonitsch, Thomas; Yeghiazaryan, Lusine; Lackner, Angelika; Brezinsek, Hans Peter; Stamm, Tanja A; König, Franz; Aletaha, Daniel; Smolen, Josef S.
Affiliation
  • Karonitsch T; Division of Rheumatology, Medical University of Vienna, Wien, Austria thomas.karonitsch@meduniwien.ac.at.
  • Yeghiazaryan L; Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Wien, Austria.
  • Lackner A; Division of Rheumatology and Immunology, Medical University of Graz, Graz, Austria.
  • Brezinsek HP; Division of Rheumatology and Immunology, Medical University of Graz, Graz, Austria.
  • Stamm TA; Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Wien, Austria.
  • König F; Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Wien, Austria.
  • Aletaha D; Division of Rheumatology, Medical University of Vienna, Wien, Austria.
  • Smolen JS; Division of Rheumatology, Medical University of Vienna, Wien, Austria.
RMD Open ; 8(2)2022 10.
Article in En | MEDLINE | ID: mdl-36270746
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Interferon Type I Limits: Humans Language: En Journal: RMD Open Year: 2022 Document type: Article Affiliation country: Austria
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Interferon Type I Limits: Humans Language: En Journal: RMD Open Year: 2022 Document type: Article Affiliation country: Austria